EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
9.65
-0.26 (-2.62%)
At close: Apr 1, 2026, 4:00 PM EDT
9.50
-0.15 (-1.55%)
After-hours: Apr 1, 2026, 7:37 PM EDT
EUDA Health Holdings Stock Forecast
EUDA's stock price has decreased by -86.74% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for EUDA Health Holdings stock has a target of 55, which predicts a 469.95% increase from the current stock price of 9.65.
Price Target: $55 (+469.95%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for EUDA Health Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Greenridge Global | Greenridge Global | Strong Buy Maintains $120 → $55 | Strong Buy | Maintains | $120 → $55 | +469.95% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
9.42M
from 4.01M
Increased by 134.73%
Revenue Next Year
27.78M
from 9.42M
Increased by 195.03%
EPS This Year
0.02
from -9.46
EPS Next Year
0.17
from 0.02
Increased by 750.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 9.7M | 28.6M |
| Avg | 9.4M | 27.8M |
| Low | 9.0M | 26.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 141.6% | 203.7% |
| Avg | 134.7% | 195.0% |
| Low | 125.5% | 183.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.02 | 0.18 |
| Avg | 0.02 | 0.17 |
| Low | 0.02 | 0.17 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 775.0% |
| Avg | - | 750.0% |
| Low | - | 716.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.